Author
Ana‐Maria Orbai
Also Known As
A-M Orbai, A. M. Orbai, A.-M. Orbai, A.M. Orbai, ANA-MARIA ORBAI, Alexis Ogdie, Ana Maria Orbai, Ana-Maria Orbai, Ana‐Maria Orbai, Gordon, Caroline
199
Publications
10.6K
Citations
34
H-Index
45
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 14 | 15 | 772 |
2 | Public Health | 3 | 3 | 89 |
3 | Health Sciences | 1 | 1 | 26 |
4 | Nursing | 1 | 1 | 20 |
5 | Community Health Sciences | 1 | 1 | 20 |
Ana‐Maria Orbai
×
60
Publications
8.9K
Citations
27
H-Index
| Year | Citations | |
|---|---|---|
2012 | 5.1K | |
2016 | 899 | |
2018 | 465 | |
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial Peter Nash, Bruce Kirkham, Masato Okada, Rheumatoid DisorderRheumatologySpirit-p2 Phase 3Autoimmune DiseaseMedicine | 2017 | 390 |
2015 | 210 | |
2017 | 131 | |
2014 | 110 | |
2019 | 79 | |
2018 | 78 | |
2019 | 67 |
Page 1
Page 1